BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 38761266)

  • 1. Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers.
    Yan J; Wang B; Zhang G; Liao C; Zhao Z; Wang P; Wang X
    Curr Treat Options Oncol; 2024 May; ():. PubMed ID: 38761266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
    Gross ND; Miller DM; Khushalani NI; Divi V; Ruiz ES; Lipson EJ; Meier F; Su YB; Swiecicki PL; Atlas J; Geiger JL; Hauschild A; Choe JH; Hughes BGM; Schadendorf D; Patel VA; Homsi J; Taube JM; Lim AM; Ferrarotto R; Yoo SY; Mathias M; Han H; Seebach F; Lowy I; Fury MG; Rischin D
    Lancet Oncol; 2023 Nov; 24(11):1196-1205. PubMed ID: 37875144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant relatlimab and nivolumab in resectable melanoma.
    Amaria RN; Postow M; Burton EM; Tetzlaff MT; Ross MI; Torres-Cabala C; Glitza IC; Duan F; Milton DR; Busam K; Simpson L; McQuade JL; Wong MK; Gershenwald JE; Lee JE; Goepfert RP; Keung EZ; Fisher SB; Betof-Warner A; Shoushtari AN; Callahan M; Coit D; Bartlett EK; Bello D; Momtaz P; Nicholas C; Gu A; Zhang X; Korivi BR; Patnana M; Patel SP; Diab A; Lucci A; Prieto VG; Davies MA; Allison JP; Sharma P; Wargo JA; Ariyan C; Tawbi HA
    Nature; 2022 Nov; 611(7934):155-160. PubMed ID: 36289334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
    Gross ND; Miller DM; Khushalani NI; Divi V; Ruiz ES; Lipson EJ; Meier F; Su YB; Swiecicki PL; Atlas J; Geiger JL; Hauschild A; Choe JH; Hughes BGM; Schadendorf D; Patel VA; Homsi J; Taube JM; Lim AM; Ferrarotto R; Kaufman HL; Seebach F; Lowy I; Yoo SY; Mathias M; Fenech K; Han H; Fury MG; Rischin D
    N Engl J Med; 2022 Oct; 387(17):1557-1568. PubMed ID: 36094839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features and clinical significance of tertiary lymphoid structure in cutaneous squamous cell carcinoma.
    Wu YH; Wu F; Yan GR; Zeng QY; Jia N; Zheng Z; Fang S; Liu YQ; Zhang GL; Wang XL
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2043-2050. PubMed ID: 35881141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and management of skin cancers in very elderly patients: A real-world challenge for clinicians.
    Lai M; Pampena R; Mirra M; Raucci M; Benati E; Borsari S; Lombardi M; Banzi M; Castagnetti F; Palmieri T; Piana S; Ramundo D; Pellacani G; Longo C
    Exp Dermatol; 2022 Oct; 31(10):1554-1562. PubMed ID: 35723894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery combined with photodynamic therapy versus surgery alone for the treatment of non-melanoma skin cancer and actinic keratosis: A retrospective cohort study.
    Yang W; Liu L; Yang W; Wang D
    Dermatol Ther; 2022 Aug; 35(8):e15652. PubMed ID: 35716107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma.
    Zeng Q; Yang J; Ji J; Wang P; Zhang L; Yan G; Wu Y; Chen Q; Liu J; Zhang G; Wang X
    Oncoimmunology; 2022; 11(1):2061396. PubMed ID: 35402079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence kinetics study of twice laser irradiation based HpD-PDT for nonmelanoma skin cancer.
    Li C; Wang P; Wang D; Shi L; Zhou Z; Zhang L; Zhang G; Chen C; Wang X
    Lasers Surg Med; 2022 Sep; 54(7):945-954. PubMed ID: 35391497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
    Kibbi N; Owen JL; Worley B; Wang JX; Harikumar V; Downing MB; Aasi SZ; Aung PP; Barker CA; Bolotin D; Bordeaux JS; Cartee TV; Chandra S; Cho NL; Choi JN; Chung KY; Cliby WA; Dorigo O; Eisen DB; Fujisawa Y; Golda N; Halfdanarson TR; Iavazzo C; Jiang SIB; Kanitakis J; Khan A; Kim JYS; Kuzel TM; Lawrence N; Leitao MM; MacLean AB; Maher IA; Mittal BB; Nehal KS; Ozog DM; Pettaway CA; Ross JS; Rossi AM; Servaes S; Solomon MJ; Thomas VD; Tolia M; Voelzke BB; Waldman A; Wong MK; Zhou Y; Arai N; Brackett A; Ibrahim SA; Kang BY; Poon E; Alam M
    JAMA Oncol; 2022 Apr; 8(4):618-628. PubMed ID: 35050310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma.
    Bertrand N; Guerreschi P; Basset-Seguin N; Saiag P; Dupuy A; Dalac-Rat S; Dziwniel V; Depoortère C; Duhamel A; Mortier L
    EClinicalMedicine; 2021 May; 35():100844. PubMed ID: 33997740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese guidelines on the clinical application of 5-aminolevulinic acid-based photodynamic therapy in dermatology (2021 edition).
    Shi L; Wang H; Chen K; Yan J; Yu B; Wang S; Yin R; Nong X; Zou X; Chen Z; Li C; Chen L; Zhang C; Zhang F; Zheng H; Zheng M; Tu P; Xu J; Tao J; Kang X; Zeng K; Lu Y; Yu N; Lei X; Pan M; Ju Q; Gu H; Wang X
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102340. PubMed ID: 33991660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma.
    Zelin E; Zalaudek I; Agozzino M; Dianzani C; Dri A; Di Meo N; Giuffrida R; Marangi GF; Neagu N; Persichetti P; Toffoli L; Conforti C
    Curr Treat Options Oncol; 2021 Mar; 22(4):35. PubMed ID: 33725197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic Directions.
    Niebel D; Sirokay J; Hoffmann F; Fröhlich A; Bieber T; Landsberg J
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):835-846. PubMed ID: 32383019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of advanced cutaneous squamous-cell carcinoma.
    Gellrich FF; Hüning S; Beissert S; Eigentler T; Stockfleth E; Gutzmer R; Meier F
    J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():38-43. PubMed ID: 31833610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
    Liew YCC; De Souza NNA; Sultana RG; Oh CC
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma.
    Keyal U; Bhatta AK; Zhang G; Wang XL
    J Am Acad Dermatol; 2019 Mar; 80(3):765-773. PubMed ID: 30393093
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.